Proizvodnja rdečih krvnih celic iz pluripotentnih matičnih celic psov

Researchers at Osaka Metropolitan University have successfully generated red blood cell-like cells from canine induced pluripotent stem cells (iPSCs), marking a significant step forward in veterinary medicine and potentially offering insights for human blood production. The breakthrough was achieved by a team led by Professor Shingo Hatoya at the university’s Graduate School of Veterinary Science. The study, published in Stem Cells Translational Medicine, outlines a method to produce these cells using a combination of cell culture techniques and genetic tracking tools. The research highlights the potential for creating lab-made blood products for both canine and human applications, though further refinement is needed before such cells could be used in clinical settings. The process began with canine iPSCs, which were developed through collaboration with TOKIWA-Bio Inc. These stem cells were cultured in clusters and guided through a series of developmental stages to mimic the natural formation of red blood cells. During this process, progenitor cells, precursors to all blood cell types, were observed emerging. These progenitors eventually produced cells containing hemoglobin, the essential protein responsible for carrying oxygen in red blood cells. To monitor the progress of differentiation, the researchers employed CRISPR-Cas9 technology to edit the genome of the iPSCs, introducing a gene that causes the cells to emit a green fluorescent signal when expressing glycophorin A (GYPA), a well-known marker of mature red blood cells. This technique enabled the scientists to visually track the development of red blood cell-like cells in real time. More than 96 percent of the analyzed cells showed GYPA expression under optimal conditions, indicating successful differentiation. Despite these encouraging results, the cells generated so far are not yet fully mature red blood cells suitable for transfusion. According to Professor Hatoya, only approximately 3 percent of the cells underwent enucleation, the loss of the nucleus, which is a defining characteristic of mature mammalian red blood cells. Enucleation is critical for the function and longevity of red blood cells in circulation. Without this final stage, the cells would not be viable for use in blood transfusions. The research team acknowledges that future efforts must focus on enhancing the maturation process and investigating variations in cell behavior across different cell lines. The implications of this study extend beyond veterinary medicine. Dogs share many physiological similarities with humans, making them valuable models for studying diseases and treatments that could apply to both species. By developing methods to generate red blood cells from canine iPSCs, scientists may gain deeper insights into the mechanisms of blood cell development and refine techniques that could ultimately benefit human patients. For instance, the ability to produce transfusable red blood cells in the lab could alleviate shortages in human blood banks and reduce reliance on donor blood. However, the transition from canine research to human application requires additional validation and optimization. The study underscores the growing importance of iPSC-based technologies in regenerative medicine. Induced pluripotent stem cells, derived from adult cells that have been genetically reprogrammed to an embryonic-like state, offer a versatile tool for generating various cell types. In recent years, researchers have explored their potential for treating conditions ranging from diabetes to heart disease. The ability to create blood cells from iPSCs represents another frontier in this field, one that could revolutionize how blood-related disorders are managed. Professor Hatoya and his team plan to continue refining their methods to improve the efficiency and functionality of the generated red blood cells. Their next steps include exploring factors that influence enucleation and identifying ways to enhance the overall yield of mature cells. As they work toward this goal, the research opens up new possibilities for both veterinary and human medicine, demonstrating the value of interdisciplinary approaches in advancing scientific knowledge.